The comparative activity of gill ATPase was examined in the bluegill sunfish (Lepomis macrochirus), fathead minnow (Pimephales promelas), and golden shiner (Notemigonus crysoleucas). Basal Na/K ATPase activity was highest in bluegill sunfish (1.46 mumol Pi/mg protein/hr) and lowest in golden shiners (1.01 mumol Pi/mg protein/hr). While a stimulation of Na/K ATPase activity was observed at an exposure concentration of 1 micrograms Cd/liter in the bluegill sunfish and fathead minnows, an inhibition of enzymatic activity was observed at higher exposure concentrations (10 and 100 micrograms Cd/liter). Gill Na/K ATPase activity in golden shiners was not significantly influenced by cadmium exposure. The observed insensitivity of Na/K ATPase in golden shiners may, in part, be related to high background concentrations of cadmium in gill tissue. In all three species examined, gill residual ATPase activity was not significantly altered by cadmium exposure.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/0147-6513(87)90068-6 | DOI Listing |
Alzheimers Dement
December 2024
University of Massachusetts Medical School, Worcester, MA, USA.
Background: Neuron-derived extracellular vesicles (NDEVs) are a valuable resource for understanding brain conditions and discovering neurodegenerative diseases biomarkers, notably Alzheimer's disease (AD). Recent interest focuses on capturing neuron-specific EVs from patient-derived samples, characterizing their contents as a pathological reflection of the central nervous system (CNS). Our recent study identified ATPase Na/K Transporting Subunit Alpha 3 (ATP1A3) as a prevalent neuron-specific EV marker specifically expressed in brains.
View Article and Find Full Text PDFBackground: A purine nucleoside called cladribine has been shown to increase toxic amyloid protein and cause impaired cognition. Auranofin is a gold(I)-containing drug with anti-inflammatory, antioxidant, anti-apoptotic, anti-amyloidogenic, and neuroprotective properties. The goal of the current study was to find out the neuroprotective effects of auranofin against cladribine-induced Aβ accumulation associated with AD-like symptoms in experimental rats.
View Article and Find Full Text PDFCancer Med
January 2025
Faculty of Medicine and Health, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
Background: FXYD3 is a Na/K-ATPase modulator which is upregulated in pancreatic ductal adenocarcinoma (PDAC), but its prognostic role is unknown. This study evaluated FXYD3 expression in chemo-naive patients with surgically-resected PDAC at a single centre (1993-2014).
Method: FXYD3 expression was assessed in tumour specimens using immunohistochemistry.
Cephalalgia
January 2025
Department of Biomedicine, Health Aarhus University, Aarhus, Denmark.
Background: Familial hemiplegic migraine (FHM) types 1-3 are associated with protein-altering genetic variants in , and , respectively. These genes have also been linked to epilepsy. Previous studies primarily focused on phenotypes, examining genetic variants in individuals with characteristic FHM symptoms.
View Article and Find Full Text PDFFront Pharmacol
December 2024
School of Basic Medical Sciences, Zhejiang Chinese Medical University, Hangzhou, China.
Background: Salvianolic acid B (Sal B) is potentially the most valuable water-soluble active component in Salvia miltiorrhiza. Its chemical formula contains multiple phenolic hydroxyl groups, so it has a strong antioxidant capacity.
Objective: We aim to investigate the efficacy and the potential mechanism of Sal B in the treatment of acute ischemic stroke injury.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!